{"id":"W2581372286","doi":"10.1182/blood.v116.21.655.655","title":"Phase 2B Randomized Study of CPX-351 Vs. Cytarabine (CYT) + Daunorubicin (DNR) (7+3 Regimen) In Newly Diagnosed AML Patients Aged 60–75","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cytarabine; Regimen; Internal medicine; Clinical endpoint; Daunorubicin; Gastroenterology; Chemotherapy regimen; Randomization; Febrile neutropenia; Phases of clinical research; Leukemia; Neutropenia; Chemotherapy; Surgery; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001934332,0.001888959,0.002590069,0.0004899598,0.0004404962,0.001014587,0.0009186228,0.001605027,0.008464379],"category_scores_gemma":[0.001247497,0.0009072475,0.001143908,0.0003442212,0.001236602,0.001066155,0.0004657175,0.003359419,0.001546927],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008647021,"about_ca_system_score_gemma":0.001471511,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001103301,"about_ca_topic_score_gemma":0.001953778,"domain_scores_codex":[0.9994223,0.0002844307,0.00002810302,0.0001060191,0.00004208107,0.0001170291],"domain_scores_gemma":[0.9989216,0.0002482722,0.0001686523,0.00008342895,0.00005118337,0.0005269122],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9565926,0.02632165,0.0006958584,0.0001548249,0.0002804503,0.00004372788,0.00005415411,0.0004064147,0.004965459,0.0001018164,0.0005692249,0.009813866],"study_design_scores_gemma":[0.8061922,0.1897945,0.002177805,0.000008986722,0.000149294,0.00003566779,0.00001727234,0.0004648332,0.0004786526,0.00009717542,0.0005699773,0.00001369433],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9913657,0.0007028999,0.0004460874,0.0004155253,0.0002806088,0.004742238,0.0007526556,0.00008941655,0.001204958],"genre_scores_gemma":[0.9846118,0.0008677429,0.001991415,0.001025187,0.0005026083,0.006304956,0.001288565,0.00003186898,0.003375947],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008464379,"threshold_uncertainty_score":0.02831614,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01290343664366303,"score_gpt":0.2991489475365057,"score_spread":0.2862455108928426,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}